Mark your calendars for Regulatory Issues in Next-Generation Medicine and Pharmacogenomics, a conference sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation, the Personalized Medicine Coalition, and University of Maryland School of Medicine's Program in Personalized and Genomic Medicine.
About the Event:
Knowledge of the complete sequence of the human genome and increasing understanding of how variation in the human genome among individuals influences susceptibility to disease and responsivity to medications and/or risk for adverse side effects have created new opportunities for drug discovery and target validation clinical trial design, criteria, and endpoints to demonstrate efficacy, implementation and other issues that introduce challenging regulatory questions.
Regulatory Issues in Next-Generation Medicine and Pharmacogenomics is a one-day conference that will be held on Tuesday, September 3, 2013, in Ballroom A/B in the Southern Management Corporation Campus Center at the University of Maryland, Baltimore, located at 621 West Lombard Street in Baltimore, MD. This conference, sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation, the Personalized Medicine Coalition (PMC), and the University of Maryland School of Medicine's Program in Personalized and Genomic Medicine, will host invited speakers from the FDA, academia, industry, hospital and health care systems, health insurance companies, electronic health record vendors, and other stakeholders to discuss regulatory issues surrounding personalized medicine and pharmacogenomics.
About the Sponsors:
 |
The Center of Excellence in Regulatory Science and Innovation (CERSI) focuses on modernizing and improving the ways in which drugs and medical devices are developed and evaluated. It is a collaborative partnership between the Food and Drug Administration (FDA) and the Baltimore and College Park campuses of the University of Maryland. |
 |
Launched in 2004, the Personalized Medicine Coalition (PMC) educates policymakers and the public, and promotes new ways of thinking about health care. Today, the organization represents a broad spectrum of more than 200 innovator, academic, industry, patient, provider, and payer communities as it seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. |
 |
The Program in Personalized and Genomic Medicine, housed in the University of Maryland School of Medicine, strives to facilitate the pace of discovery in genetics and genomics, to accelerate the translation of these new discoveries to improve patient care, and to enhance the training and education of future generations of physicians and scientists in genomic medicine and science. |
For More Informaiton:
More information, including registration, agenda, accommodations, and parking and directions, can be found on this website.